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(A) Hepatitis B virus (HBV) is now the major cause of infectious viral hepatitis in U.S.
military personnel and probably also in the civilian population over 15 yearsofage. (B)The inci-
dence oficteric, viral hepatitis is much higher in U.S. military personnel than in comparable age
groups in the civilian population. The 17- to 20-year-old enlisted men show the highest rates. (C)
In parts of the world (e.g., U.S.A., Germany) where most of the inapparent infection is caused
by the adw subtype of HBV, most of the acute clinical disease is caused by the ayw subtype. In
the U.S.A. and Germany, 95% or more of HB,Ag isolates from U.S. military personnel with
acute hepatitis is ayw. (D) It may be many years before one can expect to have sufficient data
for a decision as to the possible availability of an effective HBV vaccine. Accordingly, a decision
is urgently needed regarding either the immediate use ofthe best practically available hepatitis
immune gamma globulin, that can be prepared by modern techniques, for the prevention of
hepatitis in U.S. military personnel or postponement of such use until an adequate and properly
controlled trial can be carried out in active duty military personnel in an areaofhigh incidence.
Recent advances in our knowledge ofviral hepatitis have rendered invalid the con-
tinuing custom of equating so-called "infectious hepatitis" with "hepatitis A" and of
limiting the diagnosis of"hepatitis B" to thoseviral hepatitis patients in whose serum
the surface antigen (HB.Ag) ofhepatitis B virus (HBV) has been demonstrated dur-
ing the first 10 days after onset ofjaundice. While common source food- and water-
borne outbreaks have been shown to be invariably caused by hepatitis A virus
(HAV), such outbreaks account for only a small portion of icteric, viral hepatitis
reported in recent years in the U.S.A. or in U.S. military personnel at home and
abroad. Recent studies of an outbreak at Fort Hood, Texas by Major Gilbert R.
Irwin at the Walter Reed Army Institute of Research (WRAIR) showed that while
highly specific tests for HB, Ag in the serum were positive in only 35% of394 military
patients with viral hepatitis during the first 7-14 days after onset ofjaundice, supple-
mentary tests for antibody vs the core antigen (HB,) and vs HBsAg indicated that
about 90% of all cases were hepatitis B, i.e., caused by HBV (personal communica-
tion). Similar studies by Robert Purcell at the National Institute of Allergy and In-
fectious Diseases on sera obtained more than 20 years ago from U.S. military
personnel with infectious hepatitis in Korea yielded comparable results (personal
communication). Thus, the data that have been reported at this symposium on the in-
cidence of hepatitis A and of hepatitis B in military personnel as well as similar
reports by the Center for Disease Control (CDC, HEW) for the civilian population
must be regarded as inaccurate and misleading in the absence of the tests for the
HBV antibodies just mentioned and for the recently reported highly specific HAV
antibodies that cannot as yet be carried out on a routine basis. What is urgently
needed in civilian and military populations are well-planned, collaborative clinical
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and laboratory studies to determine how much of total icteric, viral hepatitis in
persons ofdifferent ages and socioeconomic status are caused by HAV and HBV in
different geographic areas.
The next question I wish to address is whether icteric, viral hepatitis is currently
really much more frequent in military personnel than in civilians of comparable age
and sex, or whether differences in reporting ofthis disease in the military and civilian
populations prevent meaningful conclusions. In the military, there are records of
patients with the icteric disease who are sick enough to seek help in military medical
installations, and the main problem is that data based on admissions diagnosis may
show smaller or larger numbers of cases than the more reliable discharge records,
and using the date of discharge rather than of admission may result in different an-
nual totals. With few exceptions, the differences are not too great. On the other
hand, a recently reported study (1) on the greater New Haven civilian population
during 1973-74 showed great variations in the completeness of reporting of viral
hepatitis from 16.7% by private physicians, 28.1% by hospitals, and 55.6% by other
health facilities. In this study it was also estimated that the annual incidence rates for
this geographic region were about 100/100,000 for urban residents and 23/100,000
for suburban residents; certainly a marked difference from the 2007/100,000 in ac-
tive duty USAREUR personnel in 1973, if one does not take into consideration the
much higher proportion of viral hepatitis in young males in the U.S.A. in recent
years.
The data in Fig. 1, reported by M. B. Gregg (2) ofCDC, and personal communica-
tions, 1971, 1973, and 1974, show the continuing increase in prevalence of viral hep-
atitis in young civilian male adults in the U.S.A. from 1966 to 1974. If one assumes
that because of underreporting the 1971-1974 peak rates of 55 to 62/100,000 of the
20- to 24-year age groups (Fig. 1) represent only about 25% ofthe total incidence, an
estimated rate of 200/100,000 is still significantly lower than the rates of 475, 524,
and 588/100,000 reported for the U.S. Army in the USA (CONUS) for 1971, 1972,
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TABLE I
Incidenceof Icteric, Viral Hepatitis: Reported Cases/100,000/Year, U.S. Army Active Duty Personnel
vs Indigenous Civilian Population (All Ages) in U.S.A. and West Germany
Group 1971 1972 1973
Civilians (all ages) in U.S.A. 34 31 28
U.S. Army
Total ZI (CONUS) 475 524 588
Total outside ZI 535 469 1366
Ryukyus 1108 767 607
Korea 922 869 620
Vietnam 955 996 65
Total European Command 100 409 1742
(445)a (737) (2077)
Civilian population (all ages)
ofWest Germany 15 16 19
a Numbers in parentheses, USAREUR Preventive Medicine rates based on discharge clinical records
on cover sheets with dateofdischarge determining the month ofrecord.
and 1973 (see Table 1; except when otherwise noted the data in this table are derived
from the reports in "Health ofthe Army" that were supplied to me by Major Dennis
R. Swanson, M.C., SGO, U.S. Army, and may represent admissions diagnosis). It is
noteworthy that in 1974 the rate in active duty U.S. Army CONUS personnel based
on discharge diagnosis was only 293/100,000, orjust halfofthe 1973 rate, while that
in Europe was 1236/100,000 (data provided by Major Robert Chloupeck, M.C., Pre-
ventive Medicine, SGO).
The recent increasing incidence of viral hepatitis in active duty USAREUR
personnel (predominantly Germany) since 1971 is real, although the exact numbers
are difficult to evaluate. The most extensive and thorough compilation of data is
contained in a document entitled "Hepatitis Epidemic Among U.S. Army Military
Personnel, 1971-1974, USAREUR" of June 21, 1974 by Maj. Gilbert R. Lavoie,
M.C. (Chief, Communicable Disease and Epidemiology Branch, HQ, U.S.A.
Medical Command, Europe), Cpt. Leonard Garret, Jr., MSC (Environmental
Health Engineering, 10th Medical Laboratory), and Cpt. Fred McClain, MSC
(Chief, USAREUR Central Medical Records Agency). Despite some differences in
total numbers resulting from reporting the diagnosis on admission vs that on dis-
charge (in the first 4 months of 1974 it was 1151 on admission vs 1092 on discharge)
and despite underreporting prior to 1971, the total number of cases for the 3 years
prior to 1971 was only about 640. During the 4 years of 1971-1974, the total number
of cases was about 8600, with a peak of 3975 for 1973 based on discharge diagnosis
with the date of admission determining the month of record (Preventive Medicine,
HQ, USAMEDCOMEUR). Although the 1973 attack rate of over 2000/100,000/
annum (Table 1) dropped to 1236/100,000/annum in 1974, it was again up to
1360/100,000/annum during the first 3 months of 1975 (see Fig. 2).
There is no question that there is much more viral hepatitis among active duty
U.S. Army personnel stationed in Europe than among personnel stationed in the
U.S.A., and much more than among civilians in the U.S.A. and German civilians in
Germany (see Table 1), no matter how big a proper correction factor for under-
reporting of civilian cases may be. It is of interest, however, to note that the usual
seasonal incidence, as well as the unusual peak incidence in 1973 in U.S. Army
personnel (Fig. 2), corresponds exactly to that in the German civilian population of
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FIG. 2. Hepatitis in active Army, USAREUR. From reportofMajor Gilbert R. Lavoie, M. C. et al.
West Germany (Fig. 3). It is also noteworthy that during the unusual seasonal peak
of the 1973 epidemic in August and September, the age-specific attack rate among
U.S. enlisted personnel was highest in the 17 to 20 age group, regardless of grade
(Fig. 4). During these peak months in 1973 when the attack rates were as high as
6930/100,000/annum among the 17- to 20-year-olds in the enlisted grades 1-4, they
were 680 in the 25- to 27-year-old enlisted men of the same grade, 690 in the 2nd
lieutenants, and only 5/100,000/annum among the 221,000 U.S. nonmilitary de-
pendents aged 15 and over in Germany at that time (data from report ofLavoie et al.
cited above). These statistics clearly point to the fact that there is something special
about the life style of the active duty U.S. Army personnel in Germany, and espe-
cially that ofthe 17- to 20-year-old enlisted men, that accounts for thehigh incidence
ofhepatitis among them.
RIA tests for HB, Ag in the serum from USAREUR patients obtained in Sep-
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FIG. 3. Total civilian cases of infectious hepatitis in West Germany. From report of Major Gilbert R.
Lavoie, M. C. et al.
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FIG. 4. Age-specific rates of enlisted personnel with hepatitis in USAREUR, July and August, 1973.
From report ofMajor Gilbert R. Lavoie, M. C. et al.
tember and December, 1973 and April, 1974 regularly yielded positive results in 70%
(personal communication from WRAIR), and it is therefore highly probable that
supplementary antibody tests vs HB, Ag and HBc Ag would have shown that this epi-
demic was caused by hepatitis B virus. The increasing number of drug addicts and
"dirty needle" transmission have been generally blamed for the marked increase in
viral hepatitis among U.S. military personnel in Germany and elsewhere, but I find it
difficult to accept this explanation as the mainfactor for a number of reasons. I can-
not see how it can account for the seasonal incidence, especially the unusual summer
peak in the 1973 epidemic (Fig. 2). In November, 1973 a new hepatitis coding system
adopted by the Army included information on both tests for HB, Ag and history of
drug abuse within 8 months prior to onset. According to Maj. Dennis R. Swanson,
M.C. (Preventive Medicine, SGO) who examined the worldwide hepatitis records for
January-July, 1974, 50% of HB, Ag positive hepatitis cases were recorded as having
no recent history ofdrug use, but he believed that there was still a great reluctance to
place a drug diagnosis into the discharge summary (letter of20 September, 1974). It
is noteworthy that among civilian hepatitis patients, aged 15 and over, tests for
HB Ag have been positive with equal frequency among those who denied or admitted
parenteral drug use (Table 2).
It seems to me necessary to recall that the preponderance ofhepatitis B virus as a
major cause of viral hepatitis in U.S. military personnel antedates the so-called
"drug culture," based on the unpublished studies of Purcell on sera from patients in
Korea in the early 1950's, mentioned earlier. Moreover, as was already pointed out
by Dr. Lewellys Barker in this symposium, sexual intercourse must be considered as
an important potential mode oftransmission among a number ofother pathways that
do not involve "needle sticks." Promiscuous sexual intercourse has been a way of
Army life, especially for young soldiers, for a very long time.
Tests for HB, Ag antigenemia by older methods, not including radioimmunoassay,
on 175 U.S. military patients in 1970 in Vietnam showed 41% positive despite the fact
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TABLE 2
HB, Ag in Acute, Icteric Viral Hepatitis in Los Angeles, California (U.S.A.)
in Relation to Parenteral Drug Useb
HB Again patients ofindicated age (years)
15-24 25 and older Total
Parenteral Number Percentage Number Percentage Number Percentage
drug use tested HBsAg tested HBsAg tested HBsAg
Denied 148 52 115 41 263 47
Admitted 145 51 62 55 207 52
aHb, Ag measured by counterelectrophoresis; much less sensitive than current methods.
bFrom data ofJames Mosley et al., 1971.
that many of the sera were obtained several weeks after onset. Serum obtained
within 7 days after onset yielded 52% positive tests by the less sensitive older
methods (3). If the correction factor that Maj. Gilbert Irwin ofWRAIR found to be
indicated as a result of the tests for HBsAg and HB, antibodies in the 1973 Fort
Hood, Texas outbreak is also appliable elsewhere, then all or most ofthe viral hepa-
titis in the U.S. military in Vietnam was also caused by HBV. Only 15 of the 175
military hepatitis patients in Vietnam had a history ofillicit drug use.
In view of these findings one may question how much, if any oficteric, viral hepa-
titis in U.S. military personnel is caused by HAV (except for theoccasional common
source food- or water-borne outbreaks), and how much, if any, by the hypothetical
hepatitis C virus (except some few cases post-transfusion). While the answer can
come only from urgently needed well-planned studies in which the best available
specific laboratory tests for HAV and HBV infection (and HCV? when and if avail-
able) will be used, the preliminary data now on hand strongly suggest (but do not es-
tablish) that HBV is currently the predominant viral cause of hepatitis in U.S.
military personnel throughout theworld.
One cannot think rationally about various potential methods ofprevention ofhepa-
titis B without consideration of our present knowledge of HBsAg subtypes, and
whether HBs Ag is the only surface antigen by which the HBV particle can attach it-
self to susceptible cells. Besides the common group antigen "a," HB, Ag has addi-
tional antigenic determinants of "d" or "y," and of "w" and "r" that are the
phenotypic expressions ofdifferent HBV genotypes. The four known combinations of
adw, ayw, adr, and ayr breed true on serial passages in humans and chimpanzees. In-
dividual infections are as a rule caused by a single subtype; i.e., the HBs Ag recovered
from any one patient or healthy carrier is usually adw, ayw, adr; ayr is very rare. The
resulting HBs Ag antibodies correspond to the infecting subtypes and can be more
readily used to determine the prevalence of infection (not disease) caused by the
different subtypes in different population groups.
In the U.S.A. the HBs Ag recovered from healthy, volunteer blood donors is adw
in 85% and ayw in 15%. The HBs Ag antibody in healthy persons without a history of
hepatitis exhibits about the same proportion. A similar predominance ofthe subtype
adw has been found in other parts of North America, in South America, in northern
and western Europe, in South Africa, East Africa, Indonesia, the Philippines,
Taiwan, and Hong Kong. A predominance of about 80 to 85% ayw vs 15-20% ofadw
has been found in Romania, Italy, Greece, Yugoslavia, Israel, Egypt, Iran, Pakistan,
India, and West Africa. The borderline between adw and ayw in Africa is between
Kenya and North Uganda. The subtype adr is predominant in Oceania, Thailand
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(83% adr vs 17% adw), Burma, The People's Republic of China, Korea, and the
Kyushu and Honshu islands of Japan. The borderline between adw and adr predomi-
nance in Japan is between Kyushu and Okinawa. Some of the more recent data on
the geographic distribution of HB, Ag subtypes given here are from the discussion by
Dr. Kusuya Nishioka (4).
In the U.S.A. and northwestern Europe, parenteral drug addicts with hepatitis and
their non-drug-using intimate contacts with hepatitis yield HB. Ag that is ayw in 80
to 100% of the isolates, although ayw is present in only 15% of healthy carriers in
these regions. The ayw subtype is also disproportionately prevalent in sporadic acute
icteric, viral hepatitis unrelated to drug use in these regions ranging from 40-50% in
civilian adults in the U.S.A., France, and Denmark to 88% in Canada and 94% in ac-
tive duty military personnel in the U.S.A. In the recent outbreaks in.U.S. military in
Germany, ayw was identified in 98% of the HB, Ag isolates, although it is present in
only 20% of healthy civilian German carriers. In Southeast Asia (Thailand,
Cambodia, Vietnam) where ayw was not detected in the native population (either
patients with hepatitis or healthy carriers) and where 92% of the HB. Ag isolates
from Thai patients with hepatitis was adr, the HB, Ag recovered from U.S. military
personnel with hepatitis in Vietnam was ayw in 52%, adr in 20%, adw in 5% and ad (r
and w determinants not specified) in 23% (5). On the other hand, 33 subtyped HB, Ag
isolates from U.S. military hepatitis patients in Korea (1967-1969) yielded 85% ad
and 15% ay (6). HB, Ag recovered from 10 fatal cases of acute icteric viral hepatitis
in civilians in the U.S.A. were reported as exclusively ay (7). Thus, while both ad and
ay subtypes of HBV can produce acute icteric hepatitis, the data cited above suggest
the existence of pathogenic variants, with a higher frequency of virulent strains
among those with the ay determinants. The situation may perhaps be comparable to
the three types of poliovirus, all of which can produce paralytic disease in man; but
over the years 90% ofparalytic disease is caused by the type1 virus.
Recent work on the e antigen of HBV (8) .indicates that one cannot exclude the
possibility that it is another HBV surface antigen, distinct from the HB, Ag spherical
particle, and that antibody vs the e antigen may also play a protective role.
As regards prevention of viral hepatitis in U.S. military personnel, it seems to me
that the immediate question is whether or not hepatitis immune gamma globulin, pre-
pared by current techniques involving elimination of HB, Ag-containing blood, with
known antibody content against various HBV antigens and against HAV should be
used in a manner comparable to that employed in the 1967-1969 field trial in Korea
(9), i.e.,5 ml repeated at 5- to 7-month intervals during the period of service, or
whether it should not be used until another trial, controlled for incidence of HAV and
HBV hepatitis by modern techniques, is carried out in an area of especially high inci-
dence.
According to information I received from Major John M. McLean, MSC, Epide-
miologist (Office of The Surgeon General, Department of the Army) gamma globulin
is now being used prophylactically in U.S. Army personnel in Korea once a year in
the autumn. It was previously used during the period of 1964-1969 and reintroduced
in 1973 (with a recommendation that 5-ml doses be administered once every 6
months) when the hepatitis incidence more than doubled in 1970-72 after discon-
tinuation of gamma globulin. It is noteworthy that while the hepatitis attack rate in
U.S. military personnel was 1236 and about 1360/100,000 in 1974 and 1975, respec-
tively, in Europe, it was only 280 and 290/100,000 in Korea during the same period.
The continuing statements that gamma globulin can protect against HAV but not
against HBV disease are based on tests carried out in 1958-1960 (10) when it was not
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yet known that a large proportion of sporadic "infectious hepatitis" was caused by
HBV, and also because of the ineffectiveness of conventional preparations against
posttransfusion or post-"needle-stick" hepatitis. Maj. Gilbert Irwin has reviewed in
this symposium several trials in which "standard" gamma globulin may have had an
effect on naturally transmitted HBV infection not involving "needle sticks."
In myjudgment, the assumption that most HBV hepatitis in U.S. military person-
nel is now transmitted by "needle sticks" is not supported by the available data, but
on the basis of the amount of parenteral drug use still occurring in Armed Forces
personnel a portion of the hepatitis is unquestionably so transmitted, and this would
have to be taken into consideration in any policy decision. Sincegamma globulin may
only convert clinically apparent, icteric hepatitis into clinically inapparent infections,
and since chronic hepatitis is more frequently associated with inapparent HBV infec-
tions, it is necessary to obtain some estimate ofthe risk ofchronic hepatitis following
inapparent HBV infection in reaching a decision on extensive use ofgamma globulin
for prevention oficteric HBV disease.
A decision on the use or study of gamma globulin in U.S. Army personnel in
Europe cannot be postponed on the assumption that an effective HBV vaccine is
"around the corner." The data obtained thus far with purified HB, Ag vaccine (de-
void of e antigen) are very preliminary on very small numbers of chimpanzees. They
as yet tell us nothing about duration ofimmunity, about the roleofsubtypes in cross-
immunity when only HB, Ag is used, and about the hazards, if any, of repeated
inoculations of such antigens if multiple boosters should be required. Trials on even
the smallest numbers of human beings should, in my judgment, be postponed until
the answers to these and other questions become available from more extensive
studies on larger numbers of chimpanzees; all of which cannot be accomplished
within a few years.
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